Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

BioMed Central full text link BioMed Central Free PMC article
Full text links

Actions

Share

Review
.2013 Jan 14:8:10.
doi: 10.1186/1750-1172-8-10.

Malignant atrophic papulosis (Köhlmeier-Degos disease) - a review

Affiliations
Review

Malignant atrophic papulosis (Köhlmeier-Degos disease) - a review

Athanasios Theodoridis et al. Orphanet J Rare Dis..

Abstract

DEFINITION OF THE DISEASE: Malignant atrophic papulosis (MAP), described independently by Köhlmeier and Degos et al., is a rare, chronic, thrombo-obliterative vasculopathy characterized by papular skin lesions with central porcelain-white atrophy and surrounding teleangiectatic rim.

Epidemiology: Less than 200 cases have been described in the literature. The first manifestation of MAP usually occurs between the 20th and 50th year of life.

Clinical description: The cutaneous clinical picture is almost pathognomonic. The histology is not consistent but in most cases it shows a wedge-shaped connective tissue necrosis in the deep corium due to a thrombotic occlusion of the small arteries. In the systemic variant, manifestations mostly occur at the intestine and central nervous system.

Etiology: The etiopathogenesis of the disease remains unknown, a genetic predisposition may occur. Vasculitis, coagulopathy or primary dysfunction of the endothelial cells have been implicated.

Diagnostic methods: Diagnosis is only based on the characteristic skin lesions. DIFFERRENTIAL DIAGNOSIS: It depends on the clinical presentation of MAP, but systemic lupus erythematosus and other connective tissue diseases need to be considered.

Management: No effective treatment exists for the systemic manifestations, while compounds that facilitate blood perfusion have achieved a partial regression of the skin lesions in single cases.

Prognosis: An apparently idiopathic, monosymptomatic, cutaneous, benign variant and a progressive, visceral one with approx. 50% lethality within 2-3 years have been reported. Systemic manifestations can develop years after the occurrence of skin lesions leading to bowel perforation and peritonitis, thrombosis of the cerebral arteries or massive intracerebral hemorrhage, meningitis, encephalitis, radiculopathy, myelitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cutaneous involvement of Köhlmeier-Degos disease showing scattered typical lesions on the lower extremities of a female patient.
Figure 2
Figure 2
Characteristic lesions with porcelain-white center und a surrounding erythematous rim on the upper extremities of a male patient.
Figure 3
Figure 3
Biopsy from skin lesions showing a wedge-shaped necrosis, arteriolar obliteration, epidermal atrophy, hyperkeratosis and disarrangement of the collagen fibers in the corium.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Köhlmeier W. Multiple Hautnekrosen bei Thrombangitis obliterans. Arch Dermatol Syph (Wien) 1941;181:783–792.
    1. Degos R, Delort J, Tricot R. Dermatite papulosqameuse atrophiante. Bull Soc Fr Derm Syph. 1942;49:148–150.
    1. Snow JL, Muller SA. Degos syndrome: malignant atrophic papulosis. Semin Dermatol. 1995;14(2):99–105. doi: 10.1016/S1085-5629(05)80004-5. - DOI - PubMed
    1. Vázquez-Doval FJ, Ruiz de Erenchun F, Páramo JA, Quintanilla E. Malignant atrophic papulosis. A report of two cases with altered fibrinolysis and platelet function. Clin Exp Dermatol. 1993;18(5):441–444. doi: 10.1111/j.1365-2230.1993.tb02246.x. - DOI - PubMed
    1. Torrelo A, Sevilla J, Mediero IG, Candelas D, Zambrano A. Malignant atrophic papulosis in an infant. Br J Dermatol. 2002;146(5):916–918. doi: 10.1046/j.1365-2133.2002.04677.x. - DOI - PubMed

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full text links
BioMed Central full text link BioMed Central Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp